IBDEI0E6 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6829,2)
 ;;=^336562
 ;;^UTILITY(U,$J,358.3,6830,0)
 ;;=339.84^^55^572^33
 ;;^UTILITY(U,$J,358.3,6830,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6830,1,4,0)
 ;;=4^339.84
 ;;^UTILITY(U,$J,358.3,6830,1,5,0)
 ;;=5^Headache,Primary Exertional
 ;;^UTILITY(U,$J,358.3,6830,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,6831,0)
 ;;=339.85^^55^572^34
 ;;^UTILITY(U,$J,358.3,6831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6831,1,4,0)
 ;;=4^339.85
 ;;^UTILITY(U,$J,358.3,6831,1,5,0)
 ;;=5^Headache,Primary Stabbing
 ;;^UTILITY(U,$J,358.3,6831,2)
 ;;=^336564
 ;;^UTILITY(U,$J,358.3,6832,0)
 ;;=339.89^^55^572^19
 ;;^UTILITY(U,$J,358.3,6832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6832,1,4,0)
 ;;=4^339.89
 ;;^UTILITY(U,$J,358.3,6832,1,5,0)
 ;;=5^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,6832,2)
 ;;=^336565
 ;;^UTILITY(U,$J,358.3,6833,0)
 ;;=346.40^^55^572^52
 ;;^UTILITY(U,$J,358.3,6833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6833,1,4,0)
 ;;=4^346.40
 ;;^UTILITY(U,$J,358.3,6833,1,5,0)
 ;;=5^Migraine,Menstrual
 ;;^UTILITY(U,$J,358.3,6833,2)
 ;;=^336745
 ;;^UTILITY(U,$J,358.3,6834,0)
 ;;=346.30^^55^572^51
 ;;^UTILITY(U,$J,358.3,6834,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6834,1,4,0)
 ;;=4^346.30
 ;;^UTILITY(U,$J,358.3,6834,1,5,0)
 ;;=5^Migraine,Hemiplegic
 ;;^UTILITY(U,$J,358.3,6834,2)
 ;;=^336744
 ;;^UTILITY(U,$J,358.3,6835,0)
 ;;=346.50^^55^572^54
 ;;^UTILITY(U,$J,358.3,6835,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6835,1,4,0)
 ;;=4^346.50
 ;;^UTILITY(U,$J,358.3,6835,1,5,0)
 ;;=5^Migraine,Prst w/o Aura w/o Infarct
 ;;^UTILITY(U,$J,358.3,6835,2)
 ;;=^336746
 ;;^UTILITY(U,$J,358.3,6836,0)
 ;;=346.51^^55^572^53
 ;;^UTILITY(U,$J,358.3,6836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6836,1,4,0)
 ;;=4^346.51
 ;;^UTILITY(U,$J,358.3,6836,1,5,0)
 ;;=5^Migraine,Prst w/ Aura w/o Infarct
 ;;^UTILITY(U,$J,358.3,6836,2)
 ;;=^336578
 ;;^UTILITY(U,$J,358.3,6837,0)
 ;;=346.70^^55^572^50
 ;;^UTILITY(U,$J,358.3,6837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6837,1,4,0)
 ;;=4^346.70
 ;;^UTILITY(U,$J,358.3,6837,1,5,0)
 ;;=5^Migraine,Chr w/o Aura
 ;;^UTILITY(U,$J,358.3,6837,2)
 ;;=^336748
 ;;^UTILITY(U,$J,358.3,6838,0)
 ;;=780.72^^55^572^66
 ;;^UTILITY(U,$J,358.3,6838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6838,1,4,0)
 ;;=4^780.72
 ;;^UTILITY(U,$J,358.3,6838,1,5,0)
 ;;=5^Quadraplegia,Functional
 ;;^UTILITY(U,$J,358.3,6838,2)
 ;;=^336672
 ;;^UTILITY(U,$J,358.3,6839,0)
 ;;=344.00^^55^572^67
 ;;^UTILITY(U,$J,358.3,6839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6839,1,4,0)
 ;;=4^344.00
 ;;^UTILITY(U,$J,358.3,6839,1,5,0)
 ;;=5^Quadriplegia,Unspec
 ;;^UTILITY(U,$J,358.3,6839,2)
 ;;=^101908
 ;;^UTILITY(U,$J,358.3,6840,0)
 ;;=344.1^^55^572^59
 ;;^UTILITY(U,$J,358.3,6840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6840,1,4,0)
 ;;=4^344.1
 ;;^UTILITY(U,$J,358.3,6840,1,5,0)
 ;;=5^Paraplegia NOS
 ;;^UTILITY(U,$J,358.3,6840,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,6841,0)
 ;;=907.2^^55^572^47
 ;;^UTILITY(U,$J,358.3,6841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6841,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,6841,1,5,0)
 ;;=5^Late Effect of SCI
 ;;^UTILITY(U,$J,358.3,6841,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,6842,0)
 ;;=V12.54^^55^572^45
 ;;^UTILITY(U,$J,358.3,6842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6842,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,6842,1,5,0)
 ;;=5^Hx of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,6842,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,6843,0)
 ;;=305.01^^55^573^10
 ;;^UTILITY(U,$J,358.3,6843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6843,1,4,0)
 ;;=4^305.01
 ;;^UTILITY(U,$J,358.3,6843,1,5,0)
 ;;=5^Etoh Abuse-Continuous
